Header Logo

Connection

LEO LUZNIK to Interferon Type I

Back to Details
This is a "connection" page, showing publications LEO LUZNIK has written about Interferon Type I.
LEO LUZNIK
Connection Strength
0.054
Interferon Type I
  1. Targeting PRMT9-mediated arginine methylation suppresses cancer stem cell maintenance and elicits cGAS-mediated anticancer immunity. Nat Cancer. 2024 04; 5(4):601-624.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.